The Value of miR-299-5p in Diagnosis and Prognosis of Intestinal-Type Gastric Adenocarcinoma
MicroRNAs (miRNAs) are a class of non-coding RNAs, containing about 22 nucleotides and having a pivotal function in various cellular processes. The oncogenic and tumor suppressor roles of miRNAs have been identified in cancers especially in gastric cancer, which is one of the most prevalent cancers. MiR-299-5p is located in the imprinted Dlk1-Dio3 region in chromosome 14q32. Aberrant expression of miR-299-5p was determined in solid and blood cancers. The current study was performed to assess the expression pattern of miR-299-5p in intestinal-type gastric adenocarcinoma and compare it with the normal adjacent counterparts. The expression level of miR-299-5p was investigated in forty fresh specimens which were obtained from gastric cancer patients during endoscopy. Moreover, the association of aberrant expression of miR-299-5p and clinicopathological features, as well as the susceptibility of miR-299-5p as a tumor marker, was determined. The result of qRT-PCR revealed the downregulation of miR-299-5p in intestinal-type gastric adenocarcinoma compared with adjacent tumor-free tissues (P < 0.001); this misregulation can be used as a tumor marker. Analysis of miR-299-5p misregulation did not reveal a significant correlation with clinical features. The result obtained from the present study revealed the significant downregulation of miR-299-5p in intestinal-type gastric adenocarcinoma which is consistent with previous studies showing miR-299-5p downregulation in other types of cancers. The data obtained from the current study suggest basic information which can be very helpful for future research in the field of diagnosis and treatment of gastric cancer.
KeywordsmiRNA miR-299-5p qRT-PCR Intestinal-type gastric adenocarcinoma
We would like to thank the patients, staff, and nurses in the Endoscopy and the pathology Department of Tabriz Imam Reza hospital who sincerely helped us in conducting this project.
Compliance with Ethical Standards
Conflict of interest
There is no conflict of interest.
- Adachi Y, Yasuda K, Inomata M, Sato K, Shiraishi N, Kitano S (2000) Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer 89(7):1418–1424. doi: 10.1002/1097-0142(20001001)89:7<1418:AID-CNCR2>3.0.CO;2-A CrossRefPubMedGoogle Scholar
- Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, Garcia-Foncillas J (2006) Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5:29. doi: 10.1186/1476-4598-5-29 CrossRefPubMedPubMedCentralGoogle Scholar
- Shevde LA, Metge BJ, Mitra A, Xi Y, Ju J, King JA, Samant RS (2010) Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin. J Cell Mol Med 14(6b):1693–1706. doi: 10.1111/j.1582-4934.2009.00821.x CrossRefPubMedGoogle Scholar
- Zehavi L, Avraham R, Barzilai A, Bar-Ilan D, Navon R, Sidi Y, Leibowitz-Amit R (2012) Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. Mol Cancer 11:44. doi: 10.1186/1476-4598-11-44 CrossRefPubMedPubMedCentralGoogle Scholar